LUMIGAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug LUMIGAN contains one active pharmaceutical ingredient (API):

1 Bimatoprost
UNII QXS94885MZ - BIMATOPROST

Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F (PGF), that does not act through any known prostaglandin receptors.

Read about Bimatoprost

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LUMIGAN Eye drops, solution European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01EE03 Bimatoprost S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10046R, 10053D, 5551E, 8620Q
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501003601171312, 501003602176318, 501006601138311, 501006602134318
Country: CA Health Products and Food Branch Identifier(s): 02324997
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00265425, 01682007, 02667168, 02667205, 04446112, 05900524, 05900530, 06846264, 07111493, 10070148, 10070154, 10114756, 10114762, 10199497, 10353389, 10402538, 10408937, 10418137, 10637626, 10742004, 11522397, 11522405, 11542371, 12342935, 13350693, 14032995, 14215916, 14241144, 14275574, 15634182, 15656344, 17199253, 17558516
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 25.847-08-04, 30173-04-12
Country: EE Ravimiamet Identifier(s): 1198289, 1198290, 1459896, 1459908, 1612022, 1612033, 1638154
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 02205003, 02205003IP, 102205006
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 007275, 010706, 115209, 181536
Country: FR Base de données publique des médicaments Identifier(s): 60135981, 66203859
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 167478, 167479, 219097, 375928, 376738, 381475
Country: HK Department of Health Drug Office Identifier(s): 60394, 62570
Country: IE Health Products Regulatory Authority Identifier(s): 41901, 77154, 77404, 77432
Country: IT Agenzia del Farmaco Identifier(s): 035447022, 035447059
Country: JP 医薬品医療機器総合機構 Identifier(s): 1319757Q1027
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1005610, 1029636, 1052831, 1052832, 1068565, 1068566, 1071583
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 467M2001
Country: NL Z-Index G-Standaard Identifier(s): 14748444
Country: NL Z-Index G-Standaard, PRK Identifier(s): 104655, 61506, 92681
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10164, 13594, 15430
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100127269, 100221672
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68880001, W68880002
Country: SG Health Sciences Authority Identifier(s): 14365P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 3983011, 3983012
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699490561287
Country: US FDA, National Drug Code Identifier(s): 0023-3205

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.